Director/PDMR Shareholding
Drax Group
490.20p
17:05 19/04/24
Monday, 27 February 2023
Trifast plc
(the "Company")
Director/PDMR shareholding
The Company announces that on Monday 27 February 2023, Mr Scott Mac Meekin, Interim Chief Executive Officer, purchased a total of 14,388 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). Following this transactions, Mr Mac Meekin has a beneficial interest of 14,388 Ordinary Shares in the Company.
Enquiries:
Trifast plc
Christopher Morgan
Company Secretary
Tel: +44 (0) 1825 769696
www.trifast.com
The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Scott Mac Meekin
| ||||
2. | Reason for the notification | |||||
a. | Position/status | Interim Chief Executive Officer | ||||
b. | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Trifast plc
| ||||
b. | LEI | 213800WFIVE6RWK3CR22
| ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 5 pence each GB0008883927 | ||||
b. | Nature of the transaction | Purchase of shares by Scott Mac Meekin
| ||||
c. | Price(s) and volume(s)
|
| ||||
d. | Aggregated information · Aggregated volume · Price |
14,388 0.695p | ||||
e. | Date of the transaction | 27 February 2023
| ||||
f. | Place of the transaction | London Stock Exchange, Main Market (XLON) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.